胆汁酸
免疫系统
法尼甾体X受体
G蛋白偶联胆汁酸受体
小肠
生物
肠道菌群
医学
生物化学
免疫学
核受体
转录因子
基因
作者
Ruicong Sun,Chunjin Xu,Bai‐Sui Feng,Xiang Gao,Zhanju Liu
标识
DOI:10.1177/17562848211018098
摘要
Bile acids are a class of cholesterol derivatives that have been known for a long time for their critical roles in facilitating the digestion and absorption of lipid from the daily diet. The transformation of primary bile acids produced by the liver to secondary bile acids appears under the action of microbiota in the intestine, greatly expanding the molecular diversity of the intestinal environment. With the discovery of several new receptors of bile acids and signaling pathways, bile acids are considered as a family of important metabolites that play pleiotropic roles in regulating many aspects of human overall health, especially in the maintenance of the microbiota homeostasis and the balance of the mucosal immune system in the intestine. Accordingly, disruption of the process involved in the metabolism or circulation of bile acids is implicated in many disorders that mainly affect the intestine, such as inflammatory bowel disease and colon cancer. In this review, we discuss the different metabolism profiles in diseases associated with the intestinal mucosa and the diverse roles of bile acids in regulating the intestinal immune system. Furthermore, we also summarize recent advances in the field of new drugs that target bile acid signaling and highlight the importance of bile acids as a new target for disease intervention.
科研通智能强力驱动
Strongly Powered by AbleSci AI